United States: U.S. Supreme Court Argument On "Reverse Payments" Suggests Potential For Compromise Holding Not Advocated By FTC Or Pharmaceuticals Industry - Loeb & Loeb LLP
The Supreme Court granted certiorari in Federal Trade Commission v. Watson Pharmaceuticals, Inc. to address whether reverse payment agreements common in Hatch-Waxman litigations are presumptively anticompetitive and unlawful.
agreement
arguments
commission
court
federal
ftc
hatch-waxman
litigation
llp
loeb
payments
pharmaceuticals
states
supreme
united
watson
Found more than 1 month ago on channel
Mondaq
United States: The Federal Circuit’s Recent "Safe Harbor" Ruling Could Impact Biosimilars Drug Development - Drinker Biddle & Reath LLP
A recent Federal Circuit case, Momenta v. Amphastar, involves the Hatch-Waxman 271(e)(1) safe harbor, and is rousing the biologics and biosimilars industry.
amphastar
biddle
circuit
development
drinker
federal
hatch-waxman
llp
momenta
reath
states
united
Found more than 1 month ago on channel
Mondaq